Filter
1004
Text search:
biomedical
and
health
research
Featured
99
228
Language
Document type
515
207
131
69
46
16
10
3
2
1
1
1
Countries / Regions
51
51
34
31
29
28
26
24
23
23
21
21
16
16
13
12
12
11
10
10
10
9
8
7
7
7
7
7
6
6
6
5
5
5
5
5
5
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
379
80
56
35
31
23
8
Toolboxes
111
79
73
68
49
42
36
26
25
23
22
21
19
17
15
14
10
10
8
7
6
4
4
3
1
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that
...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available da
...
Biennial Report. SUBMITTED TO THE UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV AND AIDS
Reporting period: January 2012 – December 2013
The publication draws on pre-COVID data to highlight how children with disabilities face greater risks in the midst of this pandemic. It documents what has happened to services for children and adults with disabilities across the world
...
Background: Several studies have demonstrated that South African children and adolescents are
exposed to high levels of violent trauma with a significant proportion developing PTSD, however,
limited resources make it difficult to accurately identi
...
Frontiers in Public Health | www.frontiersin.org 1 June 2017 | Volume 5 | Article 127
These guidelines have been developed for scientific purpose with the main aim to guide the regulatory authority for evaluating probiotic products in our country.
Harm reduction: evidence, impacts and challenges
-10-
Understanding Cultural Diversity in Mental Health